Phenotypic Expression of Respiratory Diseases and Tailored Treatment in Patients with Intermediate Alpha-1 Antitrypsin Deficiency: Evidence from a Retrospective Analysis of a Selected Cohort of Patients. [PDF]
Annunziata A +15 more
europepmc +1 more source
Can Quality of Life Tests Be Useful in Patients Affected by Alpha-1 Antitrypsin Deficiency? [PDF]
Hernández-Pérez JM +3 more
europepmc +1 more source
Clinical implications of the SERPINA1 variant, MPalermo, and alpha-1 antitrypsin deficiency in Türkiye. [PDF]
Karadoğan D +8 more
europepmc +1 more source
Fazirsiran for the treatment of alpha-1 antitrypsin deficiency-associated liver disease findings from the SEQUOIA phase 2 trial. [PDF]
Liaquat T +5 more
europepmc +1 more source
Selection for somatic escape variants in SERPINA1 in the liver of patients with alpha-1 antitrypsin deficiency. [PDF]
Brzozowska N +11 more
europepmc +1 more source
Clinical and Economic Outcomes in Patients With Alpha-1 Antitrypsin Deficiency in a US Medicare Advantage Population. [PDF]
Khandelwal N +8 more
europepmc +1 more source
alpha 1-Antitrypsin deficiency.
I, Reintoft, I, Hägerstrand
openaire +1 more source

